Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 3
1977 2
1978 2
1979 1
1980 2
1982 1
1986 3
1987 1
1988 1
1989 2
1990 2
1991 3
1992 4
1993 5
1994 8
1995 8
1996 6
1997 11
1998 7
1999 12
2000 6
2001 14
2002 10
2003 9
2004 16
2005 17
2006 16
2007 16
2008 27
2009 28
2010 22
2011 31
2012 25
2013 28
2014 34
2015 32
2016 36
2017 38
2018 58
2019 66
2020 72
2021 96
2022 101
2023 98
2024 71

Text availability

Article attribute

Article type

Publication date

Search Results

937 results

Results by year

Filters applied: . Clear all
Page 1
Cardiorenal Syndrome: Pathophysiology.
Kumar U, Wettersten N, Garimella PS. Kumar U, et al. Cardiol Clin. 2019 Aug;37(3):251-265. doi: 10.1016/j.ccl.2019.04.001. Epub 2019 May 21. Cardiol Clin. 2019. PMID: 31279419 Free PMC article. Review.
Multiple Electrolytes Solution Versus Saline as Bolus Fluid for Resuscitation in Pediatric Septic Shock: A Multicenter Randomized Clinical Trial.
Sankar J, Muralidharan J, Lalitha AV, Rameshkumar R, Pathak M, Das RR, Nadkarni VM, Ismail J, Subramanian M, Nallasamy K, Dev N, Kumar UV, Kumar K, Sharma T, Jaravta K, Thakur N, Aggarwal P, Jat KR, Kabra SK, Lodha R. Sankar J, et al. Among authors: kumar uv. Crit Care Med. 2023 Nov 1;51(11):1449-1460. doi: 10.1097/CCM.0000000000005952. Epub 2023 Jun 9. Crit Care Med. 2023. PMID: 37294145 Clinical Trial.
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Combe B, Kivitz A, Tanaka Y, van der Heijde D, Simon JA, Baraf HSB, Kumar U, Matzkies F, Bartok B, Ye L, Guo Y, Tasset C, Sundy JS, Jahreis A, Genovese MC, Mozaffarian N, Landewé RBM, Bae SC, Keystone EC, Nash P. Combe B, et al. Among authors: kumar u. Ann Rheum Dis. 2021 Jul;80(7):848-858. doi: 10.1136/annrheumdis-2020-219214. Epub 2021 Jan 27. Ann Rheum Dis. 2021. PMID: 33504485 Free PMC article. Clinical Trial.
Thermal screening.
Kumar U, Parmar P, Kaur CK, Yadav S, Rajpu A. Kumar U, et al. Br Dent J. 2020 Aug;229(3):148. doi: 10.1038/s41415-020-2005-9. Br Dent J. 2020. PMID: 32811908 Free PMC article. No abstract available.
Fibrodysplasia ossificans progressiva.
Kumar RR, Dasgupta S, Suman SK, Kumar U. Kumar RR, et al. Among authors: kumar u. Rheumatology (Oxford). 2020 Jul 1;59(7):1789. doi: 10.1093/rheumatology/kez479. Rheumatology (Oxford). 2020. PMID: 31624833 No abstract available.
RAS: Circuitry and therapeutic targeting.
Singh G, Thakur N, Kumar U. Singh G, et al. Among authors: kumar u. Cell Signal. 2023 Jan;101:110505. doi: 10.1016/j.cellsig.2022.110505. Epub 2022 Oct 28. Cell Signal. 2023. PMID: 36341985 Review.
Immunogenicity of cancer cells: An overview.
Singh T, Bhattacharya M, Mavi AK, Gulati A, Rakesh, Sharma NK, Gaur S, Kumar U. Singh T, et al. Among authors: kumar u. Cell Signal. 2024 Jan;113:110952. doi: 10.1016/j.cellsig.2023.110952. Epub 2023 Oct 29. Cell Signal. 2024. PMID: 38084844 Review.
937 results